Add Press Release About Us FAQ Login
EEGI, PWRM, IBN, ICON, ICLR - Companies Wanting The Best
  Users Blogs
  Content Syndication
   Architecture
   Art and Entertainment
   Automobile
   Automotive
   Business
   Chemical
   Computer
   Computers
   Consumer
   Design
   Economy
   Education
   Employment And Careers
   Employment Opportunity
   Environment
   Events And Trade Shows
   Events and Tradeshows
   Gaming And Casinos
   Government
   Home And Family
   Industry Specific
   Industry Updates
   IndustrySpecific
   Insurance
   Interviews
   Legal And Law
   Lifestyle
   Machinery
   Maritime
   Medical
   Miscellaneous
   Non-profit
   Opinion and Editorial
   Others
   Politics
   Public Utilities
   Religion
   Science and Research
   Society
   Sports
   Teaching and Learning
   Technology
   Telecom
   Textile
   Trade
   Transportation
   Volunteer
EEGI, PWRM, IBN, ICON, ICLR - Companies Wanting The Best

chartstockalert

 

 

http://pennyomega.com/img/eegi_Vu365.jpg

Eline Entertainment Group, Inc. (PINK:EEGI) and the company's subsidiary Let The Good Times Roll has successfully merged with Midnight Express. This is a second expansion merger for Let The Good Times Roll. Let The Good Times Roll's subsidiary Midnight Express is a Florida based luxury transportation company specializing in tours of the Tampa Bay area. Midnight Express was previously geared towards tours in the party bus atmosphere, which makes for a great synergistic merger with Let The Good Times Roll as the company expands both its business model and territory.

Let The Good Times Roll employs an organic expansion and acquisition strategy to increase revenue streams and expand into the market immediately. Besides organic expansion, the company continues to seek mergers, acquisitions, and participation in various joint ventures. Let The Good Times Rollcompany seeks to achieve aggressive business growth with several mergers in the near future.

This is Eline Entertainment Group's third merger announcement in the last several days, and a second merger for the Let The Good Times Roll.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

The Board of Directors of ICICI Bank Limited (NYSE:IBN) at its meeting held at Mumbai, approved the audited accounts of the Bank for the quarter ended September 30, 2010. During the quarter, the Bank received approval of Reserve Bank of India (RBI) for merger of Bank of Rajasthan. The merger was effective from the close of business of August 12, 2010. The financials for Q2-2011 include the financials for erstwhile Bank of Rajasthan (e-BoR) for the period August 13, 2010 to September 30, 2010 (49 days). At the merger date, e-BoR had total assets of Rs. 15,596 crore (US$ 3.5 billion), advances of Rs. 6,528 crore (US$ 1.5 billion) and deposits of Rs. 13,483 crore (US$ 3.0 billion) including CASA deposits of Rs. 4,680 crore (US$ 1.0 billion).

ICICI Bank Limited provides banking products and financial services in the areas of investment banking, life and non-life insurance, venture capital, and asset management to corporate and retail customers.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

power3

Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, disclosed that Power3 has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in October or November 2010.

Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Rozetta-Cell has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Cathrin Petty as a non-executive Director. Cathrin was appointed unanimously by ICON's board of directors and, in accordance with ICON's Articles of Association, will stand for re-election by ICON's shareholders at the Company's next annual general meeting.

Cathrin is a Special Partner at Vitruvian Partners LLP and also serves as a Non Executive Director for the NHS (Strategic Health Authority for Greater London), a Non Executive Director for Circassia Ltd and an advisor to Merz Pharma GmBH

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Iconix Brand Group, Inc. (Nasdaq:ICON), previously announced financial results for the third quarter ended September 30, 2010. Total revenue for the third quarter of 2010 was approximately $96.9 million, a 63% increase as compared to approximately $59.4 million for the third quarter of 2009.

Iconix Brand Group, Inc. owns, licenses and markets a growing portfolio of consumer brands including CANDIE'S (R), BONGO (R), BADGLEY MISCHKA (R), JOE BOXER (R) RAMPAGE (R) MUDD (R), LONDON FOG (R), MOSSIMO (R) OCEAN PACIFIC(R), DANSKIN (R) ROCA WEAR(R), CANNON (R), ROYAL VELVET (R), FIELDCREST (R), CHARISMA (R), STARTER (R) and WAVERLY (R).

**************************************************************

pobc4

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Eline Entertainment Group, Inc. (EEGI.PK). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).

Terms     |    Privacy     |    Contact us     |    Site Map     |    Links
Sitemap   1 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 
32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 
62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 
92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 
122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 
152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 
182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 
212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 
242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 
272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 
302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 
332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 
362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 
392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 
422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 
452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 
482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 
512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 
542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 
572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 
602 603 604 605 606 607 608 609 610 611 612 613 614 
This website disclaims any content found in these news releases or articles. Issuers of news releases or articles are solely responsible for the accuracy of their content. If you have any questions regarding information in these news releases, please contact the issuers of the press releases.
© Copyright @ 2005. All rights Reserved. Use of our service is protected by our Privacy policy and Terms of Service.